“…The predominant inflammatory cells in nasal polyps are eosinophils, which may therefore play prominent roles in the immunologic and inflammatory processes in nasal polyps (Bernstein et al, 1995;Stoop et al, 1992Stoop et al, , 1993. Glucocorticoids are already used in hospitals to treat nasal polyps (Bachert and Gevaert, 1999;Barnes, 1998;Stoop et al, 1992) because they suppress inflammation processes by acting at different target sites. It is widely known that glucocorticoids regulate gene expression of pro-and anti-inflammatory effectors extending to adhesion molecules such as E-selectin, intercellular adhesion molecules (ICAMs), and certain mucins (Cronstein et al, 1992;Holgate and Mavroleon, 1998;Rothenberg, 1998;Tingsgaard et al, 1998).…”